During the past decade, Centre Hospitalier de Basse-Terre conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Hospitalier de Basse-Terre" #1 collaborator was "Pfizer" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Centre Hospitalier de Basse-Terre" are "Cardiac Amyloidosis" (1 trials) and "Left Ventricular Hypertrophy" (1 trials). Many other conditions were trialed in "Centre Hospitalier de Basse-Terre" in a lesser frequency.

Most popular intervention types in "Centre Hospitalier de Basse-Terre" are "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Tissue biopsies" (1 trials) and "diagnostic algorithm" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centre Hospitalier de Basse-Terre" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Centre Hospitalier de Basse-Terre". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Centre Hospitalier de Basse-Terre, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centre Hospitalier de Basse-Terre, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".